Ruch Joshua, an insider at GeneDx Holdings Corp (WGS), sold 28,463 shares of the company on November 23, 2025, at a price of $159.28 per share, totaling $4.53 million. Following this transaction, Joshua retains 28,463 shares of the company.
GeneDx Holdings operates as a health intelligence company, focusing on exome and genome testing through its subsidiary, GeneDx, LLC. The firm, headquartered in Stamford, Connecticut, employs approximately 1,000 full-time staff and went public on September 4, 2020. The company specializes in pediatric and rare disease diagnostics, offering a range of sequencing services that translate complex genomic data into actionable health insights.
As of November 18, 2025, GeneDx Holdings boasts a market capitalization of $4.0 billion with a P/E ratio of 1,922.81 and an EPS of 0.06. The company is set to announce its earnings on April 28, 2026, with an estimated revenue of $116.1 million and an EPS of -$0.04.
Insider transactions like this one provide transparency into the actions of company executives but should be considered alongside broader market trends and other financial metrics. Selling activity by a single insider is just one data point for investors, who are encouraged to analyze insider activity patterns over time and across multiple insiders to gauge sentiment effectively.